SH

Steve Hoerter

Former President and CEO

ORIC Pharmaceuticals Inc.

Cambridge, Massachusetts


Contact Information

Email
Unlock
LinkedIn

Company Information

Company
ORIC Pharmaceuticals Inc.
Industry
research
Employees
140.0
Seniority
C suite
Annual Revenue
2000000.0

Technologies

Outlook MailChimp SPF Microsoft Office 365 Google Cloud Hosting Bootstrap Framework Nginx Mobile Friendly WordPress.org Remote

Keywords

cancer resistance immunotherapy oncology biotechnology: pharmaceutical preparations health care biotechnology research cancer therapies resistance mechanisms clinical trials oric-114 egfr her2 prostate cancer biopharmaceutical precision oncology hormone-dependent cancers clinical development drug discovery acute myeloid leukemia cd73 prc2 inhibitors small molecule inhibitors tumor microenvironment brain metastases anti-cancer immunity drug candidates targeted therapies patient engagement combination therapies biomarkers oncogenic drivers clinical research safety profile therapeutic resistance investigational drugs regulatory approval pharmaceutical development dmpk medicinal chemistry preclinical studies molecular targeting novel agents patient outcomes relapse prevention cancer types resistance platform biomarker strategy drug efficacy tumor types cancer treatment autologous models oncology drug development synthetic lethality hospital & health care health wellness & fitness

Get Full Contact Details

Subscribe to reveal email addresses and export contacts.

View Plans